Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Omuro

Showing results (11-20 of 86) with videos related to

Pageof 9
Sort By:
Neuro-Oncology|September 7, 2012
Outcomes of the oldest patients with primary CNS lymphoma treated at Memorial Sloan-Kettering Cancer CenterMary R Welch, Antonio Omuro, Lisa M Deangelis
CNS Oncology|July 24, 2014
Bevacizumab for acute neurologic deterioration in patients with glioblastomaThomas Kaley, Craig Nolan, Alan Carver, et al.
Current Opinion in Oncology|October 2, 2007
Molecular genetic markers as predictors of response to chemotherapy in gliomasAhmed Idbaih, Antonio Omuro, François Ducray, et al.
CNS Oncology|February 2, 2018
Radiographic patterns of recurrence and pathologic correlation in malignant gliomas treated with bevacizumabAlissa Thomas, Marc Rosenblum, Sasan Karimi, et al.
Current Opinion in Neurology|October 3, 2019
Complications associated with immunotherapy for brain metastasesThuy T Tran, Lucia B Jilaveanu, Antonio Omuro, et al.
Medrxiv : the Preprint Server for Health Sciences|November 11, 2020
Comparison of Radiomic Feature Aggregation Methods for Patients with Multiple TumorsEnoch Chang, Marina Joel, Hannah Y Chang, et al.
Scientific Reports|May 8, 2021
Comparison of radiomic feature aggregation methods for patients with multiple tumorsEnoch Chang, Marina Z Joel, Hannah Y Chang, et al.
Journal of Neuro-Oncology|November 4, 2011
A phase II study of the Ras-MAPK signaling pathway inhibitor TLN-4601 in patients with glioblastoma at first progressionWarren P Mason, Karl Belanger, Garth Nicholas, et al.
Neurology|April 5, 2013
Rare cell capture technology for the diagnosis of leptomeningeal metastasis in solid tumorsLakshmi Nayak, Martin Fleisher, Rita Gonzalez-Espinoza, et al.
Cancers|March 11, 2023
Comparing Detection Schemes for Adversarial Images against Deep Learning Models for Cancer ImagingMarina Z Joel, Arman Avesta, Daniel X Yang, et al.
Pageof 9

Showing results (11-20 of 86) with videos related to

Sort By:
Pageof 9
Neuro-Oncology|September 7, 2012
Outcomes of the oldest patients with primary CNS lymphoma treated at Memorial Sloan-Kettering Cancer CenterMary R Welch, Antonio Omuro, Lisa M Deangelis
CNS Oncology|July 24, 2014
Bevacizumab for acute neurologic deterioration in patients with glioblastomaThomas Kaley, Craig Nolan, Alan Carver, et al.
Current Opinion in Oncology|October 2, 2007
Molecular genetic markers as predictors of response to chemotherapy in gliomasAhmed Idbaih, Antonio Omuro, François Ducray, et al.
CNS Oncology|February 2, 2018
Radiographic patterns of recurrence and pathologic correlation in malignant gliomas treated with bevacizumabAlissa Thomas, Marc Rosenblum, Sasan Karimi, et al.
Current Opinion in Neurology|October 3, 2019
Complications associated with immunotherapy for brain metastasesThuy T Tran, Lucia B Jilaveanu, Antonio Omuro, et al.
Medrxiv : the Preprint Server for Health Sciences|November 11, 2020
Comparison of Radiomic Feature Aggregation Methods for Patients with Multiple TumorsEnoch Chang, Marina Joel, Hannah Y Chang, et al.
Scientific Reports|May 8, 2021
Comparison of radiomic feature aggregation methods for patients with multiple tumorsEnoch Chang, Marina Z Joel, Hannah Y Chang, et al.
Journal of Neuro-Oncology|November 4, 2011
A phase II study of the Ras-MAPK signaling pathway inhibitor TLN-4601 in patients with glioblastoma at first progressionWarren P Mason, Karl Belanger, Garth Nicholas, et al.
Neurology|April 5, 2013
Rare cell capture technology for the diagnosis of leptomeningeal metastasis in solid tumorsLakshmi Nayak, Martin Fleisher, Rita Gonzalez-Espinoza, et al.
Cancers|March 11, 2023
Comparing Detection Schemes for Adversarial Images against Deep Learning Models for Cancer ImagingMarina Z Joel, Arman Avesta, Daniel X Yang, et al.
Pageof 9